Biogen BeLux News and Activities
Presence
Headquarters: Netherlands
Biogen is one of the...
Biogen is a company listed under the stock ticker BIIB (US).
Biogen has a direct presence in 9 countries.Biogen has 9 subsidiaries including Biogen ANZ, Biogen BeLux and Biogen Canada.
They are in:
Acquisition, funding and merger involving Biogen.
- Biogen has announced the acquisition of RayThera (posted on June 18 2026).
- Biogen has announced the acquisition of Apellis Pharmaceuticals (posted on March 31 2026).
- Biogen has announced the acquisition of Alcyone Therapeutics (posted on September 24 2025).
Executives
View the org chart displaying its 5 main executives
Most searched biographies at Biogen BeLux
- Julie De Smet, Head, Cluster, Benelux
- Michiel Rijkeboer, Head, Regulatory Affairs
- Hans van Loenen, Medical Director
Popular executive movements at Biogen
- Michael Parini will join the company as Chief Legal Officer on Aug. 3, 2026 (posted on July 15 2026).
- Jessie Lee has joined the company as Head of Commercial Learning and Development (posted on June 24 2026).
- Maria Freire, who was Director, is promoted to Chairman of the Board (posted on February 13 2026).
Click here to view some more movements at Biogen
Create your alert
to follow the executive moves at Biogen BeLux.
Biotechnology
Biogen has 2,425 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).
Popular M&A news in Biotechnology
- Clearside Biomedical has gone out of its bankruptcy protection (posted on July 15 2026).
- Attovia Therapeutics has filed its IPO. Its stock ticker will be ATTO. (posted on July 15 2026).
- The new name of ChemoTech is Neem’s Hill. (posted on July 15 2026).
Popular contacts in Biotechnology
News
Press releases by Biogen BeLux
Social media about Biogen BeLux
- Biogen BeLux on Wikipedia, Google News & Yahoo Finance
- Biogen BeLux on LinkedIn, X (Twitter) & YouTube
